Replies to post #177551 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Kaufmann was the PI before becoming an employee and CMO of Anavex. I believe the PI must be independent from the sponsor.

This document may hold the answer: https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm341008.pdf

Hard to imagine Kaufmann will have no financial interest in the trial outcome.